In summary, we identify the correlation between inhibition of platelet activation and amelioration of intestinal barrier dysfunction during sepsis, which is associated with the suppression of CD40L-CD40-TRAF6 signaling pathway and the reduction of EGC activation. The gene discussed is CD40LG; the disease is Sepsis.